diphenyldiselenide has been researched along with Diabetic Neuropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Huan, Y; Huang, K; Ji, W; Lei, L; Li, C; Liu, H; Liu, Q; Liu, S; Shen, Z; Sun, S; Wang, X; Zhou, J | 1 |
1 other study(ies) available for diphenyldiselenide and Diabetic Neuropathies
| Article | Year |
|---|---|
Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stress.
Topics: Animals; Benzene Derivatives; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Kelch-Like ECH-Associated Protein 1; Male; NF-E2-Related Factor 2; Organoselenium Compounds; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2020 |